Nectar Lifescience Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Nectar Lifescience Ltd is ₹ 12.28 as of 05 May 15:30 . The p/e ratio of Nectar Lifescience Ltd changed from 21.5 to 0 over 4 quarters. This represents a CAGR of -100.00% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The market cap of Nectar Lifescience Ltd changed from ₹ 417.13 crore to ₹ 515.35 crore over 5 quarters. This represents a CAGR of 18.43% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The revenue of Nectar Lifescience Ltd for the Dec '25 is ₹ 88.81 crore as compare to the Sep '25 revenue of ₹ 0.74 crore. This represent the growth of 11901% The revenue of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Nectar Lifescience Ltd for the Dec '25 is ₹ 33.53 crore as compare to the Sep '25 ebitda of ₹ -175 crore. This represent the decline of -119% The ebitda of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Nectar Lifescience Ltd changed from ₹ 2.97 crore to ₹ 14.27 crore over 7 quarters. This represents a CAGR of 145.20% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The dividend payout of Nectar Lifescience Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Nectar Lifescience Ltd

Nectar Lifescience Limited was initially incorporated on June 27, 1995 as 'Surya Medicare Limited'.
On March 26, 2004, Company changed the name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'.
NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
It is a global pharmaceutical company specializing in Cephalosporins.
Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Nectar Lifescience Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Nectar Lifescience Ltd or Sanofi India Ltd?

Market cap of Nectar Lifescience Ltd is 238 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Nectar Lifescience Ltd and Sanofi India Ltd?

The stock performance of Nectar Lifescience Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nectar Lifescience Ltd and Sanofi India Ltd?

As of May 5, 2026, the Nectar Lifescience Ltd stock price is INR ₹12.28. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Nectar Lifescience Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Nectar Lifescience Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.